Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.
Related Posts
Medicare’s new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.
Treasury Secretary Bessent says market woes are more about tech stock sell-off than Trump’s tariffs
“The Nasdaq peaked on DeepSeek day so that’s a Mag 7 problem, not a MAGA problem,” Bessent said.
Tesla owners are trading in their EVs at record levels, Edmunds says
Data from Edmunds shows that Tesla owners have been trading in their vehicles at record levels since CEO Elon Musk joined Trump’s White House.